CIK 0001497253
- Non-accelerated filer
- Smaller reporting company
VivoSim Labs, INC.
Sign in to watch- Ticker
- VIVS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271488943
- Phone
- +1 858-224-1000
- Business address
- 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
- Open-market buys, last 90 days
- $2,804
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-01-23 | Murphy Keith Chairman, CEO and President | Sale | −4,900 | $3.51 | $17K | 6,059,015 |
| 2016-12-14 | Murphy Keith Chairman, CEO and President | Sale | −50,000 | $3.72 | $186K | 6,063,915 |
| 2016-11-16 | Presnell Sharon Collins Chief Scientific Officer | Shares withheld for taxes | −1,210 | $3.26 | $4K | 116,745 |
| 2016-11-16 | Murphy Keith Chairman, CEO and President | Shares withheld for taxes | −7,200 | $3.26 | $23K | 6,113,915 |
| 2016-11-16 | Gallant Paul General Manager | Shares withheld for taxes | −1,160 | $3.26 | $4K | 45,375 |
| 2016-11-16 | David Eric CSO & EVP Pre-Clinical Dev | Shares withheld for taxes | −1,745 | $3.26 | $6K | 703,356 |
| 2016-11-16 | Bush Jennifer General Counsel & Secretary | Shares withheld for taxes | −1,210 | $3.26 | $4K | 47,576 |
| 2016-09-16 | Murphy Keith Chairman, CEO and President | Shares withheld for taxes | −1,394 | $4.00 | $6K | 6,121,115 |
| 2016-08-23 | KUSSMAN CRAIG Chief Financial Officer | Grant or award | +132,000 | 132,000 | ||
| 2016-08-23 | KUSSMAN CRAIG Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +330,000 | 330,000 | ||
| 2016-08-19 | Presnell Sharon Collins Chief Scientific Officer | Shares withheld for taxes | −1,109 | $4.00 | $4K | 117,955 |
| 2016-08-19 | Murphy Keith Chairman, CEO and President | Shares withheld for taxes | −5,129 | $4.00 | $21K | 6,122,509 |
| 2016-08-19 | Gallant Paul General Manager | Shares withheld for taxes | −965 | $4.00 | $4K | 46,535 |
| 2016-08-19 | David Eric CSO & EVP Pre-Clinical Dev | Shares withheld for taxes | −1,205 | $4.00 | $5K | 705,101 |
| 2016-08-19 | Bush Jennifer General Counsel & Secretary | Shares withheld for taxes | −1,214 | $4.00 | $5K | 48,786 |
| 2016-08-17 | Maroun Richard E Director | Grant or award | +7,500 | 7,500 | ||
| 2016-08-17 | Maroun Richard E Director | Grant or award | +7,500 | 15,000 | ||
| 2016-08-17 | Maroun Richard E Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2016-08-17 | Maroun Richard E Director | Grant or award · Stock Option (Right to Buy) | +18,500 | 18,500 | ||
| 2016-08-17 | Malloy Kirk Director | Grant or award | +7,500 | 7,500 |
Page 10 of 13 · 259 trades